Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
The role of growth factors as a therapeutic approach to demyelinating disease.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Acute disseminated encephalomyelitis after tetanus vaccination of a pregnant woman in Senegal.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Recommendations for the management of multiple sclerosis relapses.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
The role of Acinetobacter in the pathogenesis of multiple sclerosis examined by using Popper sequences.
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Assessing upper limb function in multiple sclerosis.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.

Pages